All News Xiangxue Pharmaceutical Co.,Ltd.

Equities

300147

CNE100000Y92

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-06-05 pm EDT			5-day change	1st Jan Change
3.2 ^CNY	-5.04%		-9.09%	-37.86%

Apr. 29	Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 24	Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 24	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Ji Qingsong agreed to acquire 18.87% stake in Hubei Tianji Pharmaceutical Co., Ltd. from Xiangxue Pharmaceutical Co.,Ltd. for CNY 200 million.	23-08-01	CI
Xiangxue Pharmaceutical Co.,Ltd. announced that it expects to receive CNY 959.884 million in funding	23-08-01	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-21	CI
Xiangxue Pharma Trims Losses in 2022	23-01-24	MT
China's COVID scare sparks run on flu medicines, test kits as far away as Australia	22-12-15	RE
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Wuhan Yiyi Tongguan Enterprise Management Partnership (Limited Partnership) and Hubei Qingsong Yueyue Pharmaceutical Co., Ltd. agreed to acquire 35% stake in Hubei Tianji Pharmaceutical Co., Ltd. from Xiangxue Pharmaceutical Co.,Ltd. for CNY 385 million.	22-06-30	CI
Xiangxue Pharmaceutical Co.,Ltd. Approves Board Elections	22-06-27	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-22	CI
Xiangxue Pharmaceutical Unlocks 3.4 Million Restricted Shares; Shares Rally 13%	22-01-03	MT
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-26	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-27	CI
Xiangxue Pharma's Shareholder Scraps Stake Sale Plan	21-07-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Xiangxue Pharmaceutical Co.,Ltd.

Equities

300147

CNE100000Y92

All News

Filters